Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

蒿甲醚片 - NMPA Drug Approval Details

Approvals/NMPA/Artemether Tablets

Approved

化学药品

Artemether Tablets

昆药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Jul 6, 2020
Approval ID: 7LeafokMS3y
Company: 昆药集团股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeafokMS3y
Approval Number: 国药准字H10970019
Generic Name: 蒿甲醚片
Generic Name En: Artemether Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 40mg
Reg Date: 2020-07-06
Company Name: 昆药集团股份有限公司
Production Company Name: 昆药集团股份有限公司
Production Company Address: 云南省昆明市西郊七公里
Company Detail Path: /organization/kpc-pharmaceuticals-inc
Production Company Detail Path: /organization/kpc-pharmaceuticals-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 6, 2020

Approval ID

7LeafokMS3y

Type

化学药品

Back to NMPA Approvals